fashion -WSS

fashion

author：entertainment 2025-10-01 07:40:18 - browse：3489

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

leisure time

hotspot

WSS

Study: AI not yet building 'n

Future doctors need a strong humanities education

Head of FDA's diagnostics center, who led through Covid, retires

Future doctors need a strong humanities education

Future doctors need a strong humanities education

First recipient of genetically engineered pig kidney has died

hotspot

fashion

leisure time

Medical leaders decry Supreme Court decision on affirmative action

Study: Adult vaccinations pay for themselves in societal benefits

How to save PrEP access — and even expand it

Study: AI not yet building 'n

Sports medicine is finally prioritizing gender equality

TikTok, Instagram influencers need more rules for drug ads

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Elevance, private equity launch primary care company

Trump demands the U.S. pay no more for drugs than other countries … again

A pediatrician calls for Congress to pass the child tax credit deal

leisure time

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Study: AI not yet building 'n

Mass General, Mayo Clinic look to monetize custom

Update the Apgar Score to remove skin color

Making AI in medicine accessible to smaller, and rural hospitals

Shionogi licenses Pompe disease therapy from Maze Therapeutics

leisure time

Wikipedia

hotspot

leisure time